Back to CVE records
High 7.1Published Sep 26, 2026

CVE-2026-100718Froxlor before 2.3.12 Authentication Bypass via EmailSender.add

Updated under an hour ago ()

Does this affect you?

It affects froxlor. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.19%, higher than 8% of scored CVEs.

Froxlor through 2.3.10 does not enforce the mail.allow_external_domains policy in the EmailSender.add API command. When an administrator has enabled the allowed-sender feature but disabled external allowed-sender domains (mail.enable_allow_sender = 1, mail.allow_external_domains = 0), an authenticated customer with API access can still use EmailSender.add to register an arbitrary external sender address for their mailbox, which is stored despite the policy. This creates a bypass between the UI/administrator configuration and the API, and — where the generated mail configuration consumes the allowed-sender table — allows a customer to authorize sender identities outside their hosted domains, facilitating sender spoofing. Fixed in 2.3.12.

CVSS
7.1 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:H/A:N
Weakness (CWE)
CWE-276
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.19% (percentile 8)
Assigned by
VulnCheck
NVD analysis
Deferred
Record last updated
Sep 26, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
froxlor froxlor
froxlor:froxlor (from the name)
before 2.3.12; 2.3.12 not affected
CNA record

References

  • vendor-advisory
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.